September 28-29, 2017 9th Annual Women in Public Service. Portsmouth, Virginia

Wednesday, June 14, 2017, 9:00 — 11:15 a.m. Fostering competition in the pharmaceutical distribution chain

What if cooperative ownership of pharmaceutical companies and distribution chain OWNED up to 60% would  that make a difference globally in drug distribution and pricing? Could community ownership make a difference in ensuring equal pricing and distribution for all?

June 11, 2017

Fostering competition in the  pharmaceutical distribution  chain Wednesday, June 14, 2017, 9:00 to 11:15 a.m. EDT On Wednesday, June 14, Brookings and USC will host  a forum to explore the many segments of the drug  distribution chain and examine proposals to reduce  price markups through increased competition. Register to attend | Register to watch When: Wednesday, June 14, 2017, 9:00 — 11:15 a.m. Where: The Brookings Institution, Falk Auditorium, 1775 Massachusetts Ave, NW, Washington, DC What:  Although a great deal of attention concerning prescription drug prices centers on the prices charged by pharmaceutical manufacturers themselves, markups in the distribution chain—pharmacy benefit managers, wholesalers, and pharmacies—are often substantial. Despite the large role that these actors play, little is known about the discounts they negotiate or markups they charge and how those relate to what patientsultimately pay. On Wednesday, June 14, the USC-Brookings Schaeffer Initiative for Innovation in Health Policy will host a forum to explore the many segments of the drug distribution chain and examine proposals to reduce price markups through increased competition. The event will feature a presentation of two new papers: one estimating profitability in the distribution chains of both branded and generic drugs and another proposing a transparency scheme to foster competition in the distribution of generic pharmaceuticals. Stakeholder panels will follow the presentations of these two papers, to discuss approaches to increase competition in brand and generic drug distribution. After the session, panelists will take audience questions.